IHS performs a wide range of herbal drug development activities and clinical trials including first-in-human, dose escalation, proof of concept, bioavailability, bioequivalence, PK/PD, fed-fasted, drug-drug and drug-alcohol interactions and thorough or definitive QTc evaluations. IHS also has a well established, successful track record of performing special population studies in targeted patient populations, such as cardiovascular, metabolic, osteoarthritis, urologic and dermatologic disorders and studies involving pre- and post-menopausal women, men and women with obesity and metabolic syndrome, and men with low testosterone, erectile dysfunction and alopecia.


However, we are not limited by these key areas, as our staff members have diverse medical backgrounds, allowing us to provide expert clinical trial services in many other indications.

IHS relies on the expertise and background of its management and core staff. The diverse professional backgrounds include management and conduct of clinical trials in such key therapeutic areas as:

* Endocrinology (Diabetes mellitus, Infertility)
* Oncology (Breast cancer, non-small cell lung cancer (NSCLC), prostate cancer, T-cell leukemia, colorectal cancer, cervix cancer, gastric cancer, renal cell carcinoma)
* Respiratory disorder (Tuberculosis, Asthma, COPD)
* Cardiology (Myocardial infarction, ischemic disease, arterial hypertension, hyperlipidemia)
* Pediatrics (Nasal decongestants, GI disorders)
* Gynaecology (Bacterial vaginosis)
* Gasteroenterology (Irritable bowel syndrome)
* Infectious diseases
* Immunology

Ongoing Clinical Trials:

Ongoing Formulation Development: